Moneycontrol
HomeNewsBusinessEarningsDr. Lal Pathlabs Q4 PAT seen up 19.7% YoY to Rs 37.5 cr: Edelweiss
Trending Topics

Dr. Lal Pathlabs Q4 PAT seen up 19.7% YoY to Rs 37.5 cr: Edelweiss

Net Sales are expected to increase by 18.2 percent Y-o-Y to Rs. 260 crore, according to Edelweiss.

April 17, 2018 / 19:03 IST
Story continues below Advertisement

Aurobindo Pharma Ltd.

Edelweiss has come out with its fourth quarter (Jan-March’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Dr. Lal Pathlabs to report net profit at Rs. 37.5 crore up 19.7% year-on-year (up 4.1% quarter-on-quarter).

Net Sales are expected to increase by 18.2 percent Y-o-Y to Rs. 260 crore, according to Edelweiss.

Story continues below Advertisement

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 24.7 percent Y-o-Y (up 9.9 percent Q-o-Q) to Rs. 62.2 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.